ASF Group Limited boosted its cash reserves to over $5 million in Q2 2026, driven by divestments of non-core assets including Key Petroleum and ASF Coking Coal, while advancing investments in biotech and digital assets.
- Net cash increased to $5.19 million by quarter end
- Divestment of Key Petroleum and ASF Coking Coal assets
- BSF Enterprise advances cultivated leather commercialization
- ASF Capital develops pre-commercial digital asset platform
- Share buyback completed with 465,000 shares repurchased
Cash Boost from Strategic Divestments
ASF Group Limited (ASX:AFA) closed the June quarter with a robust cash balance of $5.19 million, a significant jump from $1.56 million at the previous quarter’s end. This surge was largely propelled by the sale of non-core investments, including the complete exit from Key Petroleum Limited and the divestment of ASF Coking Coal Pty Ltd for $3.08 million. The company also sold its 62% stake in ASF Technologies (Australia) Pty Ltd for $0.465 million, reflecting a clear shift away from certain legacy holdings.
Investment Portfolio Highlights
ASF Group continues to maintain strategic stakes in promising ventures. It holds nearly 13% of ActivEX Limited, a mineral exploration company focused on copper, gold, and critical minerals in Queensland, with a market value of approximately $0.89 million. Meanwhile, its biotech investment, BSF Enterprise PLC (LSE: BSFA), made headlines this quarter with the launch of the world’s first luxury handbag made from cultivated T-Rex Leather™. Despite the auction in Paris not meeting the reserve price, the event garnered significant international attention and industry recognition, underscoring the commercial potential of BSFA’s lab-grown leather technology.
BSFA also bolstered its financial position through a £1.0 million convertible loan note facility and a prior institutional placing, positioning it for continued advancement of its commercial strategy. ASF Group’s subsidiary, BSF Angel Funding Limited, holds over 16.6 million BSFA shares valued at around A$0.32 million.
Digital Asset Platform Development Remains Pre-Commercial
ASF Capital, the Group’s financial services arm, is progressing its institutional digital asset platform. This quarter’s activities focused on planning, regulatory compliance, and governance framework development. However, the platform remains pre-commercial with no client accounts or assets under management, and no trading or product offerings commenced. The company maintains its Australian Financial Services Licence and AUSTRAC Virtual Asset Service Provider registration, with future commercial operations contingent on board approval and regulatory adherence.
Share Buyback and Related Party Payments
During the quarter, ASF Group repurchased 464,958 shares at an average price of 6.1 cents, reflecting a modest capital management initiative. Related party payments amounted to $171,000, covering consulting, director fees, and office lease expenses.
Funding Runway and Operational Cash Flow
Despite a net operating cash outflow of $288,000 for the quarter, ASF Group’s substantial cash reserves translate into an estimated funding runway exceeding 18 quarters at current operating levels. The company reported no new borrowings or financing facilities drawn during the period, maintaining a conservative financial posture.
Bottom Line?
ASF Group’s Q2 moves sharpen its portfolio focus and cash reserves, but the success of its biotech and digital asset ventures will be critical to sustaining momentum.
Questions in the middle?
- Can BSF Enterprise convert biotech innovation into consistent commercial revenue?
- How soon will ASF Capital’s digital asset platform move beyond development to active client engagement?
- What strategic directions will ASF Group pursue with its strengthened cash position and divested non-core assets?